Hadaschik, BA; Ettinger, S; Sowery, RD et al.
Targeting prostate cancer with HTI-286, a synthetic analogue of the marine sponge product hemiasterlinInt J Cancer. Bd. 122. H. 10. 2008 S. 2368-2376
Lausch, E; Hermanns, P; Farin, HF et al.
TBX15 mutations cause craniofacial dysmorphism, hypoplasia of scapula and pelvis, and short stature in Cousin syndromeAm J Hum Genet. Bd. 83. H. 5. 2008 S. 649-55
Rink, A; Lewis, DF; Varma, S et al.
Temperature and hydration effects on absorbance spectra and radiation sensitivity of a radiochromic medium.Med Phys. Bd. 35. H. 10. 2008 S. 4545-55
Spix, C; Eletr, D; Blettner, M et al.
Temporal trends in the incidence rate of childhood cancer in Germany 1987-2004Int J Cancer. Bd. 122. H. 8. 2008 S. 1859-1867
Krämer, I
Temsirolimus - der erste zur antineoplastischen Therapie zugelassene mTOR-AntagonistKrankenhauspharmazie. Bd. 2. 2008 S. 55-60
Umlauf, VN; Kirchner, M; Schmidtke, P et al.
Th1/Th2 cytokine profiles in subtypes of juvenile idiopathic arthritis (JIA) and juvenile systemic lupus erythematodes (SLE)Arch Dis Child. Bd. 93. 2008 S. 1f (Suppl.III)
Fineschi, M; Bravi, A; Gori, T
The "slow coronary flow" phenomenon: evidence of preserved coronary flow reserve despite increased resting microvascular resistances.Int J Cardiol. Bd. 127. H. 3. 2008 S. 358-61
Colombel, JF; Watson, AJ; Neurath, MF
The 10 remaining mysteries of inflammatory bowel disease.Gut. Bd. 57. H. 4. 2008 S. 429-433
Kayhan, N; Funke, B; Conzelmann, LO et al.
The adenosine deaminase inhibitor erythro-9-[2-hydroxyl-3-nonyl]-adenine decreases intestinal permeability and protects against experimental sepsis: a prospective, randomised laboratory investigationCrit Care. Bd. 12. H. 5. 2008 S. R125
Strobel, P; Moritz, R; Leite, MI et al.
The ageing and myasthenic thymus: a morphometric study validating a standard procedure in the histological workup of thymic specimens.J Neuroimmunol. Bd. 201-202. 2008 S. 64-73